Hemostatic instrument

By designing a combination of cover parts, expansion parts and fixing parts in the hemostatic device, and fixing the injection parts by using the claws and connecting parts, the problem of high external force and dislocation and dislocation of the injection parts in the prior art are solved, and the problem of dislocation and inclination of the injection parts is realized. The stability and operation convenience of hemostatic equipment.

CN118922137APending Publication Date: 2024-11-08TERUMO KK
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380027488.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-03-18
Filing Date
2023-03-09
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing hemostatic devices require large external forces during assembly and disassembly, which may cause dislocation of the expansion components or accidentally compress the puncture site, and there is a risk of dislocation or tilt when directly connected to the injection components and the expansion components.

Method used

A hemostatic device is designed, which includes a cover member, an expansion member and a fixing member. The fixing member has a connector part and a tube part, and the injection member is fixed to the cover member through a claw part and a connecting part to prevent dislocation and passes through the inclined part. The guide cover component is inserted smoothly to reduce the pressure on the body surface.

Benefits of technology

Effectively prevent the misalignment of hemostatic devices and expansion components on the patient's body, improve the convenience and safety of operation, and ensure the stability of hemostatic devices when the patient is active.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118922137A_ABST
    Figure CN118922137A_ABST
Patent Text Reader

Abstract

Provided is a hemostasis instrument capable of simply fixing an injection member for injecting a fluid into an expansion member to a cover member and preventing the hemostasis instrument and the expansion member from being displaced when the injection member is fixed to the cover member. An injection member (200) of a hemostatic instrument (10) is provided with a connector section (210) and a tube member (220) that is connected to an expansion member (150). A fixing member (230) configured so as to be able to fix the injection member to the cover member (100) has: a main body section (231) that connects the connector section and the tube member; claw sections (233, 234) that extend parallel to the main body section toward the expansion member; and connecting sections (236, 237) configured so as to be able to insert the cover member between the main body section and the claw sections, and that connect the main body section and the claw sections. The width w3 of the claw portion is smaller than the width w4 of the main body portion at a position where the claw portion overlaps the main body portion in plan view.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a hemostatic device. Background Art

[0002] As one of the catheter surgeries, there is a known surgery in which various medical strips are introduced into the blood vessels through the puncture site formed by puncturing the blood vessels of the patient's arms, hands, and other limbs to diagnose and treat the lesion. For example, Patent Document 1 discloses a hemostatic device that stops bleeding at the puncture site formed to allow access to the blood vessels (including the distal radial artery) running through the hand.

[0003] The hemostatic device of Patent Document 1 includes: an expansion component that applies pressure to a puncture site formed on a patient's hand; a fixing component that is used to fix the pressing component to the patient's hand; an injection component that includes a port (connector portion) configured to be able to inject a fluid for expanding the expansion component and a tube portion that connects the connector portion to the inner cavity of the expansion component; and a tube fixing portion that is located in the fixing component and is configured to be able to fix the tube component.

[0004] Prior art literature

[0005] Patent Literature

[0006] Patent Document 1: International Publication No. 2019 / 090104 Summary of the invention

[0007] Problems to be solved by the invention

[0008] When a doctor or other operator (hereinafter referred to as "operator") uses the hemostatic device of Patent Document 1 to stop bleeding at a puncture site formed on a patient's hand, the operator fixes the hemostatic device using the belt bodies while placing the expansion member at the puncture site formed on the patient's hand and its surroundings, thereby preventing the expansion member from being displaced from the puncture site formed on the patient's hand. In addition, the operator fixes the tube member to the tube fixing portion, thereby preventing the tube member from moving following the movement of the patient's hand.

[0009] However, the hemostatic instrument described in Patent Document 1 may have the following problems.

[0010] In the hemostatic device of Patent Document 1, a groove for fixing the tube member is provided in the tube fixing portion. Therefore, when the operator attaches or detaches the tube member relative to the tube fixing portion, the operator needs to apply an external force to the tube member to deform the tube fixing portion in a direction to widen the groove (e.g., elastic deformation). At this time, the force required by the operator to deform the tube fixing portion in a direction to widen the groove is determined by the mechanical structure of the tube fixing portion, which is sometimes designed without considering the operability and convenience of the operator.

[0011] For example, if the force required for the operator to attach and detach the tube member to the tube fixing portion is large, the external force (force applied by the operator) is transmitted to the expansion member via the fixing member provided with the tube fixing portion, thereby accidentally applying the external force to the puncture site. In addition, since the external force is transmitted to the tube fixing portion, the external force is accidentally transmitted to the expansion member, thereby causing the expansion member to be displaced from the puncture site formed on the patient's hand.

[0012] Furthermore, Patent Document 1 discloses a hemostatic instrument having a structure in which a port capable of injecting a fluid for expanding the expansion member is directly connected to the expansion member.

[0013] The port directly connected to the expansion component is configured to protrude from the outer surface side of the cover component on the opposite side of the body surface. Therefore, when the operator expands the expansion component, when the fluid supply device such as a syringe is connected to the port, the pressing force during the connection is transmitted to the entire hemostatic device, and there is a possibility that the hemostatic device is misplaced or the hemostatic device is tilted. If the hemostatic device is misplaced or tilted as described above, there is a possibility that the expansion component is misplaced or the pressure direction applied by the expansion component to the puncture site changes to an unexpected direction.

[0014] The present invention has been made based on the above problems, and its object is to provide a hemostatic instrument that can easily fix an injection member for injecting a fluid into an expansion member to a cover member, and can prevent the hemostatic instrument and the expansion member from being misaligned when the injection member is fixed to the cover member.

[0015] Means used to solve problems

[0016] A hemostatic device according to one embodiment of the present invention comprises: a cover member configured to cover a puncture site formed on a patient; an expansion member connected to the cover member and configured to compress the puncture site; an injection member connected to the expansion member and configured to be able to inject a fluid into the expansion member; and a fixing member configured to be able to fix the injection member to the cover member, the injection member comprising a connector portion and a tube member connected to the expansion member, the fixing member comprising: a main body portion connecting the connector portion to the tube member; a claw portion extending toward the expansion member side in parallel with the main body portion; and a connecting portion configured to be able to insert the cover member between the main body portion and the claw portion and connect the main body portion to the claw portion, wherein the claw portion has a width smaller than the width of the main body portion at a position where the claw portion overlaps the main body portion when viewed from above.

[0017] A hemostatic instrument according to another embodiment of the present invention comprises: a cover member configured to cover a puncture site formed on a patient; an expansion member connected to the cover member and configured to compress the puncture site; an injection member connected to the expansion member and configured to be able to inject a fluid into the expansion member; and a fixing member configured to be able to fix the injection member to the cover member, the injection member having a connector portion and a tube member connected to the expansion member, the fixing member having: a main body portion connecting the connector portion and the tube member; a claw portion extending toward the expansion member side in parallel with the main body portion; and a connecting portion configured to be able to insert the cover member between the main body portion and the claw portion and connect the main body portion to the claw portion, the main body portion having an inclined portion inclined toward the claw portion side, at least a portion of the inclined portion being configured to be located in the main body portion closer to the base end side than the front end of the claw portion.

[0018] Effects of the Invention

[0019] The above-mentioned hemostatic device of one embodiment of the present invention can fix the injection component to the cover component by inserting the cover component between the main body and the claw in a state where the connector part and the tube part are connected by the main body of the fixing part. When the operator inserts the cover component between the main body and the claw, the operator can insert the cover component between the main body and the claw by bringing the fixing part close to the cover component in a direction roughly parallel to the surface direction of the cover component. Therefore, when the operator fixes the injection component to the cover component, it is possible to prevent unnecessary force from being applied in the direction of pressing the hemostatic device toward the body surface of the patient's body. Therefore, when the injection component is fixed to the cover component, the hemostatic device can prevent the hemostatic device installed on the patient's body from being misplaced or the expansion component from being misplaced. In addition, for example, when the above-mentioned hemostatic device is installed on the patient, the cover component sometimes bends to follow the movement of the body. In the above-mentioned hemostatic device, at the position where the claw and the main body overlap when viewed from above, the width of the claw is smaller than the width of the main body. Therefore, the hemostatic instrument can smoothly insert the cover member between the main body and the claw even in a state where the cover member is bent following the patient's movement.

[0020] A hemostatic device in another aspect of the present invention can fix the injection component to the cover component by inserting the cover component between the main body and the claw in a state where the connector part is connected to the tube part by the main body of the fixing part. When inserting the cover component between the main body and the claw, the operator can insert the cover component between the main body and the claw by making the fixing part approach the cover component in a direction substantially parallel to the surface direction of the cover component. Therefore, when the operator fixes the injection component to the cover, it is possible to prevent unnecessary force from being applied in the direction of pressing the hemostatic device toward the body surface of the patient's body. Therefore, when the injection component is fixed to the cover, the hemostatic device can prevent the hemostatic device installed on the patient's body from being misplaced or the expansion component from being misplaced. In addition, the above-mentioned hemostatic device is configured such that the main body has an inclined portion inclined toward the claw. In addition, at least a portion of the inclined portion of the main body is configured to be located at a position closer to the base end side than the front end of the claw in the main body. Therefore, the hemostatic device is configured such that when the operator inserts the cover member between the main body and the claw, the inclined portion guides the cover member to a position closer to the connecting portion than the front end of the claw. Therefore, when the operator inserts the cover member between the main body and the claw, the operator can smoothly insert the cover member between the main body and the claw while adjusting the shape of the cover member by guiding the cover member along the inclined portion. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 This is a diagram showing the hemostatic instrument according to the first embodiment, and is a plan view seen from the outer surface side of each belt body.

[0022] Figure 2 This is a diagram showing the hemostatic instrument according to the first embodiment, and is a plan view seen from the inner surface side of each belt body.

[0023] Figure 3 This is an enlarged view showing a part of the hemostatic instrument viewed from the outer surface side of the main body of the cover member.

[0024] Figure 4 This is an enlarged view showing a part of the hemostatic instrument viewed from the inner surface side of the main body of the cover member.

[0025] Figure 5 This is an enlarged view showing a part of the hemostatic instrument viewed from the outer surface side of the main body of the cover member.

[0026] Figure 6 It is along Figure 5 The partial cross-sectional view of the hemostatic instrument indicated by arrow 6A-6A is a view showing a state when the expansion member is expanded.

[0027] Figure 7 It is along Figure 5The partial cross-sectional view of the hemostatic instrument indicated by arrow 7A-7A is a view showing a state when the expansion member is expanded.

[0028] Figure 8 is a top view of the support component.

[0029] Fig. 9 This is a perspective view of the support member as viewed from the lower end side.

[0030] Fig.10 It is a perspective view showing the inner surface side of the support member.

[0031] Fig.11 It is a three-dimensional view of the injection component.

[0032] Fig.12 It is along Fig.11 A cross-sectional view of the main body of the injection component shown by arrow 12A-12A.

[0033] Fig.13 is from Fig.12 A side view of the injection component as viewed in the direction of arrow 13A is shown.

[0034] Fig.14 is from Fig.12 A bottom view of the injection component as viewed in the direction of arrow 14A is shown.

[0035] Fig.15 This is a diagram showing a state in which the cover member is inserted between the main body and the claw of the fixing member.

[0036] Fig.16 This is a diagram showing a state in which the cover member is inserted between the main body and the claw of the fixing member.

[0037] Fig.17 It is a diagram for explaining the effect of the fixing member.

[0038] Fig.18 It is a diagram for explaining the effect of the fixing member.

[0039] Fig.19 This is a diagram showing a hand (right hand) of a patient who is to use the hemostatic instrument according to the first embodiment.

[0040] Fig. 20 This is a diagram schematically showing an example of use of the hemostatic instrument according to the first embodiment.

[0041] Fig.21 This is a diagram schematically showing an example of use of the hemostatic instrument according to the first embodiment.

[0042] Fig. 22 This is a diagram schematically showing an example of use of the hemostatic instrument according to the first embodiment.

[0043] Fig.23 It is along Fig. 22 A partial cross-sectional view taken along arrows 23A-23A is shown.

[0044] Fig.24 It is along Fig. 22 A partial cross-sectional view taken along arrows 24A-24A is shown.

[0045] Fig.25 It is a diagram illustrating the fixing position of the injection member.

[0046] Fig.26 It is a diagram illustrating the fixing position of the injection member.

[0047] Fig. 27 It is a diagram illustrating the fixing position of the injection member.

[0048] Fig.28 It is a side view of the injection component of Modification 1.

[0049] Fig.29 It is along Fig.28 A partial cross-sectional view taken along arrows 29A-29A is shown.

[0050] Fig.30 It is a side view of the injection component of Modification Example 2.

[0051] Fig.31 It is a side view of the injection component of Modification 3.

[0052] Fig.32 This is a diagram schematically showing an example of use of the hemostatic instrument according to Modification 4.

[0053] Fig.33 This is a diagram schematically showing an example of use of the hemostatic instrument according to Modification 4.

[0054] Fig.34 It is a perspective view showing a fixing member according to the second embodiment.

[0055] Fig.35 is from Fig.34 The side view of the fixing component is shown as viewed in the direction of arrow 35A.

[0056] Fig.36 This is a diagram schematically showing an example of use of the fixing member according to the second embodiment. DETAILED DESCRIPTION

[0057] Hereinafter, embodiments of the present invention will be described with reference to the accompanying drawings. The following description does not limit the technical scope and meaning of the terms described in the claims. In addition, for the sake of convenience of description, the dimensional ratios of the drawings are sometimes exaggerated and different from the actual ratios.

[0058] <First Embodiment>

[0059] Figures 1 to 18 It is a figure for demonstrating the hemostatic instrument 10 of this embodiment. Figure 19 to Figure 27 This is a diagram for explaining an example of use of the hemostatic instrument 10 .

[0060] For example, Fig.19 , Fig. 22 , Fig.23 , Fig.24 As shown, the hemostatic device 10 can be used to stop bleeding at a puncture site (hereinafter also referred to as "first puncture site p1") when the sheath tube 610 of the guide sheath 600 placed at the first puncture site p1 is removed. The first puncture site p1 is formed on the patient's hand H located on the distal side (fingertip side) of the forearm Ar.

[0061] The specific positions of the puncture sites as the hemostasis targets of the hemostatic instrument 10 are not particularly limited, and in the first embodiment, the first puncture site p1 and the second puncture site p2 are exemplified.

[0062] like Fig.19 , Fig. 22 , Fig.23 , Fig.24 As shown, the first puncture site p1 is a puncture site formed in the distal radial artery (hereinafter also referred to as "blood vessel V1") of the patient, which is located at a position on the distal side of the palm artery running on the back of the right hand H1 on the distal side of the forearm Ar than the snuffbox Sb. In addition, the first puncture site p1 is located at a predetermined position between the metacarpal bone B1 of the index finger and the metacarpal bone B2 of the thumb avoiding the metacarpal bone B1 of the index finger and the metacarpal bone B2 of the thumb. It should be noted that the snuffbox Sb is a hollow of the hand located near the radius when the thumb of the patient's hand H is opened.

[0063] like Fig.19 As shown, the second puncture site p2 is a puncture site formed in the artery V2 located at the snuffbox Sb of the palmar artery running on the back side of the right hand H1. The second puncture site p2 is located on the forearm Ar side (proximal side) of the patient than the first puncture site p1, and is located between the extensor pollicis longus tendon T1 and the extensor pollicis brevis tendon T2 located on the back of the right hand H1 of the patient. In addition, the second puncture site p2 is located at a predetermined position avoiding the position of the metacarpal bone B1 of the index finger and the position of the metacarpal bone B2 of the thumb.

[0064] It should be noted that the hemostatic instrument 10 can also be used to stop bleeding at the following puncture sites: a puncture site formed at a position on the patient's left hand corresponding to the first puncture site p1 illustrated by the patient's right hand H1; a puncture site formed at a position on the patient's left hand corresponding to the second puncture site p2 illustrated by the patient's right hand H1.

[0065] Hereinafter, the hemostatic instrument 10 will be described in detail.

[0066] <Hemostatic Devices>

[0067] In summary, if Figure 1 , Figure 2 , Fig.11 , Fig. 22 , Fig.23 , Fig.24 As shown, the hemostatic device 10 comprises: a cover part 100 configured to cover the first puncture site p1; an expansion part 150 connected to the cover part 100 and configured to compress the first puncture site p1; an injection part 200 connected to the expansion part 150 and configured to be able to inject a fluid into the expansion part 150; and a fixing part 230 configured to be able to fix the injection part 200 to the cover part 100.

[0068] <Expansion Parts>

[0069] like Figure 6 , Figure 7 As shown in FIG. 1 , the expansion member 150 includes an inner cavity 150a into which a fluid can be injected. The expansion member 150 is configured to expand as the fluid is injected into the inner cavity 150a, and to contract as the fluid injected into the inner cavity 150a is discharged. The fluid used to expand the expansion member 150 is, for example, a gas such as air. Figure 6 , Figure 7 A cross-sectional view of the expansion member 150 in an expanded state is shown in FIG.

[0070] The inner cavity 150a of the expansion member 150 is connected to a tube member 220 (see Figure 1 , Figure 2 ).

[0071] like Figure 6 , Figure 7 As shown, the expansion member 150 can be formed of, for example, a film-like member (sheet), and can be connected to the sheet 120 constituting the main body 110 of the cover member 100 .

[0072] The expansion member 150 can be disposed so as to form an inner cavity 150 a between the expansion member 150 and the lower surface region 132 of the holding portion 130 formed by the sheet 120 .

[0073] The outer peripheral edge of the membrane-like member constituting the expandable member 150 constitutes the edge portion 151 of the expandable member 150. The edge portion 151 of the expandable member 150 can be connected to the sheet 120 by, for example, fusion, bonding, or the like.

[0074] The film-like member constituting the expansion member 150 can be made of, for example, a resin material having a predetermined thickness.

[0075] The material of the membrane component constituting the expansion component 150 is not particularly limited, and for example, polyolefins such as polyvinyl chloride, polyethylene, polypropylene, polybutadiene, and ethylene-vinyl acetate copolymer (EVA); polyesters such as polyethylene terephthalate (PET) and polybutylene terephthalate (PBT); various thermoplastic elastomers such as polyvinylidene chloride, silicone, polyurethane, polyamide elastomer, polyurethane elastomer, and polyester elastomer; nylon, nylon elastomer, or any combination thereof (mixed resin, polymer alloy, laminate, etc.) can be used. In addition, the cover component 100 described later can be composed of the same material as the above-mentioned materials, for example.

[0076] like Figure 6 , Figure 7 As shown, the expansion member 150 is arranged on the inner surface 110 a side of the main body 110 of the cover member 100 .

[0077] In this embodiment, the inner surface 110a of the main body 110 is composed of a surface disposed on the body surface side of the right hand H1 in the lower surface region 132 of the holding portion 130 (see Fig.23 , Fig.24 The outer surface 110 b of the main body 110 is formed by a surface on the side facing the outside in the upper surface region 131 of the holding portion 130 .

[0078] Figure 8 The top view seen from the outer surface 300 b side of the support member 300 is shown. Figure 8 2 shows the positional relationship among the expansion member 150, the support member 300 and the holding portion 130 in the contracted state. The expansion member 150 and the holding portion 130 are indicated by two-dot chain lines.

[0079] When the expandable member 150 is contracted, the expandable member 150 has a longitudinal width wa passing through the center c1 of the expandable member 150 and a lateral width wb that is orthogonal to the longitudinal width wa and passes through the center c1 of the expandable member 150 .

[0080] The center c1 of the expansion member 150 is located at Figure 8 The expansion member 150 can be formed, for example, so that the lateral width wb is shorter than the longitudinal width wa. Figure 8 In the plan view shown, the expansion member 150 has a substantially oval shape that is rotationally symmetrical about the center c1.

[0081] The expansion member 150 can be arranged so that the center c1 of the expansion member 150 is located closer to the lower end portion 302 of the support member 300 than the center of gravity G1 of the outer shape of the support member 300 .

[0082] like Fig. 20, Fig.21 , Fig. 22 As shown, the expansion member 150 has a marking portion 160 for aligning the expansion member 150 with the first puncture site p1.

[0083] In this embodiment, if Figure 8 As shown, the marking portion 160 is located at a position overlapping with the center c1 of the expansion member 150 .

[0084] like Figure 4 , Figure 8 As shown, the marking portion 160 can be composed of a transparent central portion surrounding the center c1 and a colored circular frame portion surrounding the central portion.

[0085] like Figure 6 , Figure 7 As shown, the marking portion 160 is disposed on the outer surface of the expansion member 150. It should be noted that the marking portion 160 may also be disposed on the inner surface of the expansion member 150 facing the inner cavity 150a.

[0086] The specific shape, color, and formation method of the marking portion 160 are not particularly limited. The marking portion 160 may be, for example, a circular marking composed entirely of color, a marking composed of a transparent center portion and a rectangular frame portion, or a rectangular marking composed entirely of color.

[0087] The planar shape of the expansion member 150 is not limited to the oval shape. The expansion member 150 may be configured to have a planar shape such as a circle, an ellipse, or a rectangle.

[0088] The specific structure of the expansion component 150 is not particularly limited. The expansion component 150 can be formed by joining the edge of one sheet component to another sheet component, for example, in a state where an inner cavity 150a is formed between two sheet components. In this case, the surface of one sheet component of the expansion component 150 is connected to the sheet 120 constituting the main body 110 of the cover component 100. In addition, the expansion component 150 can also be composed of a bag-shaped component formed to have an inner cavity 150a on the inside. In this case, the expansion component 150 connects a part of the surface of the bag-shaped component to the sheet 120 constituting the main body 110 of the cover component 100.

[0089] <Cover Parts>

[0090] like Figure 5 , Figure 6 , Figure 7As shown, the cover part 100 includes: a main body portion 110 where the expansion part 150 is located; a first belt portion 410 configured to be arranged between the patient's fingers and extending from the main body portion 110 in a first direction; a second belt portion 420 extending from the main body portion 110 in a second direction different from the first direction; and a third belt portion 430 opposite to the second belt portion 420 across the expansion part 150 and extending from the main body portion 110 in a third direction different from the first direction and the second direction.

[0091] like Figure 5 , Figure 6 , Figure 7 As shown in FIG. 1 , the main body 110 includes a support member 300 formed of a harder material than the expansion member 150. The support member 300 is configured such that Figure 4 , Figure 5 The illustrated plan view overlaps the expansion member 150 .

[0092] like Figure 6 , Figure 7 As shown, the main body 110 is composed of a two-layer structure, including a holding portion 130 that holds the support member 300 .

[0093] The retaining portion 130 has: an upper surface area 131 located on the outer surface 300b side of the supporting member 300; a lower surface area 132 located on the inner surface 300a side of the supporting member 300 and opposite to the upper surface area 131 across the supporting member 300; and a curved area 133 connecting the upper surface area 131 and the lower surface area 132 on the base end side of the supporting member 300 (on the lower end 302 side of the supporting member 300).

[0094] The curved region 133 is formed by folding back a portion of the main body 110 toward the first belt body 410. In the present embodiment, a portion of the sheet 120 constituting the main body 110 is folded back from the base end side of the main body 110 toward the front end side, thereby constituting the holding portion 130 having the insertion portion g into which the support member 300 can be inserted.

[0095] like Figure 5 , Figure 6 As shown, the first end portion 121 located at the front end side of the folded portion of the sheet 120 is connected to the sheet 120 at a position closer to the front end side than the upper end portion 301 of the support member 300 .

[0096] like Figure 6 , Figure 8 As shown, the base end portion 122 of the cover member 100 formed of a portion of the sheet 120 is located in the bending region 133 .

[0097] like Figure 6 As shown, in the longitudinal width wa direction of the expansion member 150 (refer to Fig.11 A), the insertion portion g of the holding portion 130 is closed between the first end portion 121 and the bending region 133. Figure 7 As shown, in the lateral width wb direction of the expansion member 150 (refer to Fig.11 A), the insertion portion g of the holding portion 130 communicates with the outside on the second belt body portion 420 side and the third belt body portion 430 side.

[0098] like Figure 4 As shown, each belt body portion 410, 420, 430 can be connected to any position of the area surrounding the main body portion 110 and the holding portion 130. In addition, each belt body portion 410, 420, 430 can be connected to the surface disposed on the body surface side of the right hand H1 in the above-mentioned area. Each belt body portion 410, 420, 430 can be connected to the main body portion 110 by, for example, welding or bonding. In addition, each belt body portion 410, 420, 430 can also be integrally formed with the main body portion 110.

[0099] like Figure 1 , Figure 2 , Figure 4 , Figure 5 As shown, the first belt body 410 includes: one end 411 connected to the main body 110 of the cover member 100 ; the other end 412 located on the opposite side of the one end 411 ; and a main body 413 extending between the one end 411 and the other end 412 .

[0100] like Fig. 22 As shown, the first belt portion 410 can be arranged so as to be hooked on the interdigital portion fb between the thumb and index finger of the patient's right hand H1 when the expandable member 150 is arranged at the first puncture site p1.

[0101] like Figure 1 , Figure 2 , Figure 4 , Figure 5 As shown, the second belt body 420 includes: one end 421 connected to the main body 110 of the cover member 100 ; the other end 422 located on the opposite side of the one end 421 ; and a main body 423 extending between the one end 421 and the other end 422 .

[0102] like Figure 1 , Figure 2 , Figure 4 , Figure 5 As shown, the third belt body 430 includes: one end 431 connected to the main body 110 of the cover member 100 ; the other end 432 located on the opposite side of the one end 431 ; and a main body 433 extending between the one end 431 and the other end 432 .

[0103] like Fig. 22 As shown, when the hemostatic instrument 10 is attached to the right hand H1 of a patient, the second belt body portion 420 and the third belt body portion 430 can be arranged so as to be wrapped around the outer circumference of the right hand H1 .

[0104] The material of each belt body 410, 420, 430 is not particularly limited, and may be composed of, for example, vinyl chloride resin, polyurethane resin, polyester resin, etc. In addition, the shape, length, thickness, etc. of each belt body 410, 420, 430 are not particularly limited.

[0105] Four fixing sites, namely a first fixing site 510 , a second fixing site 520 , a third fixing site 530 , and a fourth fixing site 540 , which can fix the cover member 100 to the right hand H1 are arranged on each of the belt parts 410 , 420 , and 430 .

[0106] like Figure 1 As shown, a first fixing portion 510 is arranged on the outer surface of the main body portion 423 of the second belt portion 420 .

[0107] like Figure 1 As shown, the second fixing portion 520 is arranged on the outer surface of the main body portion 433 of the third belt portion 430 .

[0108] like Figure 2 As shown, the third fixing portion 530 is arranged on the inner surface of the main body portion 423 of the second belt portion 420 .

[0109] like Figure 2 As shown, a fourth fixing portion 540 is arranged on the inner surface of the main body portion 413 of the first belt portion 410 .

[0110] The first fixing part 510 and the second fixing part 520 are formed by the convex side of the surface fastener. The third fixing part 530 and the fourth fixing part 540 are formed by the concave side of the surface fastener. The surface fastener in this specification is a hook and loop fastener that can be attached and detached in a surface manner, such as Magic Tape (registered trademark) and Velcro (registered trademark).

[0111] The second belt body 420 and the third belt body 430 are configured to be detachable via the third fixing portion 530 located on the inner surface of the main body 423 of the second belt body 420 and the second fixing portion 520 located on the outer surface of the main body 433 of the third belt body 430. In addition, the first belt body 410 and the second belt body 420 are configured to be detachable via the fourth fixing portion 540 located on the inner surface of the main body 413 of the first belt body 410 and the first fixing portion 510 located on the outer surface of the main body 423 of the second belt body 420.

[0112] It should be noted that the fixing parts 510, 520, 530, 540 are connected to each other by connecting the belt parts 410, 420, 430 when the hemostatic device 10 is arranged on the right hand H1, so that the cover part 100 can be fixed to the right hand H1, and the specific structure is not limited. For example, it is possible to arbitrarily omit the setting of a part of the fixing parts, change the position of the fixing parts arranged in the belt parts 410, 420, 430, etc. In addition, when the fixing parts 510, 520, 530, 540 are composed of surface fasteners, it is also possible to set the convex side and the concave side of the surface fastener to be exchanged. In addition, each fixing part 510, 520, 530, 540 can also be composed of, for example, snaps, buttons, clips, a connecting mechanism having a frame part with a protrusion and a part to be engaged with a hole that can be engaged with the frame part, etc.

[0113] <Supporting member>

[0114] Figures 8 to 10 The support member 300 is shown. The arrows X1-X2 in the figure indicate the longitudinal direction of the support member 300 (the same direction as the longitudinal width wa direction of the expansion member 150), the arrows Y1-Y2 indicate the width direction of the support member 300 (the same direction as the transverse width wb direction of the expansion member 150), and the arrows Z1-Z2 indicate the thickness direction of the support member 300.

[0115] like Figure 6 As shown, the support member 300 can be arranged in the insertion portion g included in the holding portion 130 .

[0116] like Figure 4 , Figure 5 , Figure 8 As shown, the supporting member 300 has: an upper end portion 301 located on the first belt body portion 410 side and forming an end of the supporting member 300; a lower end portion 302 forming an end on the opposite side of the upper end portion 301; and a pair of side portions 303, 304 connecting the upper end portion 301 and the lower end portion 302.

[0117] like Figure 8 , Fig. 22 As shown, when the hemostatic device 10 is mounted on the patient's right hand H1, the upper end portion 301 can be arranged on the fingertip side (front end side) of the finger. When the hemostatic device 10 is mounted on the patient's right hand H1, the lower end portion 302 can be arranged on the forearm Ar side (base end side). In addition, the upper end portion 301 forms the front end portion of the support member 300, and the lower end portion 302 forms the base end portion of the support member 300.

[0118] exist Figure 8In the plan view shown, the upper end portion 301 of the support member 300 has a linear flat portion 301a. The flat portion 301a extends substantially linearly between corner portions 306c and 306d located on the upper end portion 301 side.

[0119] exist Figure 8 The lower end portion 302 of the support member 300 has a linear flat portion 302a in the plan view shown in the figure. The flat portion 302a extends substantially linearly between corner portions 306a and 306b located on the lower end portion 302 side.

[0120] exist Figure 8 In the top view shown, the support member 300 has a middle portion 305 located between the upper end portion 301 and the lower end portion 302. The middle portion 305 is located in the middle of the longitudinal direction connecting the upper end portion 301 and the lower end portion 302.

[0121] like Figure 7 , Fig. 9 As shown, the outer surface 300 b of the supporting member 300 is curved toward the second belt portion 420 and the third belt portion 430 .

[0122] The curvature radius of the outer surface 300 b of the support member 300 may be formed to be substantially constant at each portion in the longitudinal direction of the support member 300 , for example.

[0123] exist Figure 8 The support member 300 has a position that is a center of gravity G1 of the outer shape of the support member 300 in the plan view shown.

[0124] The width w1 of the upper end portion 301 is formed to be larger than the width w2 of the lower end portion 302 in such a manner that the center of gravity G1 is located on the upper end portion 301 side relative to the middle portion 305. In the present embodiment, the support member 300 has a substantially trapezoidal shape in which the width w1 of the upper end portion 301 is formed to be larger than the width w2 of the lower end portion 302. Therefore, the center of gravity G1 of the support member 300 is located at a position offset by a predetermined distance from the middle portion 305 of the support member 300 toward the upper end portion 301 side (the lower bottom side of the trapezoidal shape).

[0125] In this manual, if Figure 8As shown in FIG. 1 , the width w1 of the upper end portion 301 of the support member 300 is defined by the size (maximum width) of the portion with the largest width in the region of the support member 300 located closer to the upper end portion 301 than the middle portion 305. In addition, the width w2 of the lower end portion 302 of the support member 300 can be defined by the length of a straight line connecting the boundary between the side portion 303 and the corner portion 306a and the boundary between the side portion 304 and the corner portion 306b. In the case where the corner portion 306a is formed in a curved shape as in the present embodiment, the boundary between the side portion 303 and the corner portion 306a is the position where the tangent line of the side portion 303 begins to change in a curved shape. Similarly, in the case where the corner portion 306b is formed in a curved shape as in the present embodiment, the boundary between the side portion 304 and the corner portion 306b is the position where the tangent line of the side portion 304 begins to change in a curved shape. In addition, when the corners 306a and 306b are not formed in a curved shape, the width w2 of the lower end portion 302 of the support member 300 may be defined by the length of a straight line connecting vertices located at the corners 306a and 306b.

[0126] The inner surface 300a of the supporting member 300 is curved toward the second belt body portion 420 and the third belt body portion 430. Figure 7 , Fig.10 As shown, the inner surface 300 a of the support member 300 is curved in a convex shape in a direction away from the expansion member 150 .

[0127] The curvature radius of the inner surface 300 a of the upper end portion 301 of the support member 300 may be formed to be smaller than the curvature radius of the inner surface 300 a of the lower end portion 302 of the support member 300 , for example.

[0128] like Fig. 9 , Fig.10 As shown, the support member 300 is configured such that the thickness t1 of the side portions 303 and 304 connecting the upper end portion 301 and the lower end portion 302 becomes thinner from the upper end portion 301 to the lower end portion 302. Figure 6 The cross-sectional view and Fig.23 In the cross-sectional view shown, the support member 300 is inclined so that the distance between the outer surface 300 b and the inner surface 300 a decreases from the upper end 301 toward the lower end 302 .

[0129] Each of the corner portions 306 a , 306 b , 306 c , and 306 d located at the four corners of the support member 300 is formed in a curved shape with rounded corners.

[0130] In the hemostatic instrument 10, it is preferred that the portion of the expansion member 150 provided with the marking portion 160, the portion of the cover member 100 overlapping with the marking portion 160 (the upper surface region 131 and the lower surface region 132 of the holding portion 130), and the portion of the support member 300 overlapping with the marking portion 160 are formed transparent. When the components 100, 150, and 300 are configured in this way, the surgeon can Figure 20 to Figure 22 When the hemostatic device 10 is mounted on the patient's right hand H1, the position of the marking portion 160 and / or the first puncture site p1 disposed on the expansion member 150 can be easily confirmed visually through the transparent portions of the components 100, 150, and 300. In addition, the transparency in this specification includes colored transparency, colorless transparency, and semi-transparency.

[0131] When the expansion part 150 is composed of the above-mentioned materials, as the constituent material of the support part 300, for example, polyolefins such as acrylic resin, polyvinyl chloride (especially rigid polyvinyl chloride), polyethylene, polypropylene, and polybutadiene; polystyrene, poly-(4-methylpentene-1), polycarbonate, ABS resin, polymethyl methacrylate (PMMA), polyacetal, polyacrylate, polyacrylonitrile, polyvinylidene fluoride, ionomer, acrylonitrile-butadiene-styrene copolymer, polyethylene terephthalate (PET), etc. can be used.

[0132] <Injection Parts>

[0133] like Figure 1 , Figure 2 , Fig.11 As shown, the injection member 200 includes a connector portion 210 and a tube member 220 , and the tube member 220 is connected to the connector portion 210 and the expansion member 150 .

[0134] like Fig.13 As shown, the connector part 210 includes a port part 211 disposed outside the fixing member 230 and a valve part 213 disposed inside the main body part 231 of the fixing member 230. The valve part 213 is briefly shown in each figure and is omitted in some figures.

[0135] A fluid supplying tool for supplying fluid to the inner cavity 150a of the expansion member 150 can be connected to the connector portion 210. For example, a syringe (not shown in the figure in this specification) can be used as the fluid supplying tool.

[0136] The valve portion 213 may be constituted by, for example, a check valve. The valve portion 213 maintains a closed state when the front barrel portion of the syringe is not inserted into the connector portion 210. When the valve portion 213 is in a closed state, the valve portion 213 cuts off the communication between the inner cavity of the tube member 220 and the outside of the connector portion 210. When the front barrel portion of the syringe is inserted into the connector portion 210, the valve portion 213 opens. If the valve portion 213 is opened, the inner cavity of the tube member 220 and the interior of the front barrel portion of the syringe are connected via the internal space 231a (refer to Fig.12 ) and connected.

[0137] like Figure 1 , Figure 2 As shown, one end of the tube member 220 is connected to the expansion member 150. The other end of the tube member 220 is connected to the main body 231 of the fixing member 230. The other end of the tube member 220 is located in the internal space 231a of the main body 231 of the fixing member 230.

[0138] The lumen of the tube member 220 communicates with the internal space 231a of the main body 231 via the other end of the tube member 220. Therefore, the lumen 150a of the expansion member 150 communicates with the internal space 231a of the main body 231 of the fixing member 230 via the lumen of the tube member 220.

[0139] When expanding the expansion member 150, the operator inserts the front barrel of a syringe (not shown) into the connector portion 210 and opens the valve portion 213. With the valve portion 213 opened, the operator presses the plunger of the syringe to inject air in the syringe into the inner cavity 150a of the expansion member 150. The expansion member 150 expands when air is injected into the inner cavity 150a.

[0140] When shrinking the expansion member 150, the operator inserts the front tube of the syringe into the connector 210 and further pulls the plunger of the syringe. By performing the above operation, the operator can discharge the air in the inner cavity 150a of the expansion member 150 into the syringe.

[0141] <Fixed parts>

[0142] Figure 11 to Figure 14 2 shows the fixing member 230 as viewed from various directions. Fig.15 , Fig.16 2 shows a state where the fixing member 230 is fixed to the cover member 100 . Fig.17 , Fig.18 The state in which the fixing member 230 is fixed to the cover member 100 is shown.

[0143] like Fig.11 , Fig.14 , Fig.16As shown, the fixing part 230 includes: a main body part 231 connecting the connector part 210 and the tube part 220; claw parts 233, 234 extending parallel to the main body part 231 toward the expansion part 150 side; and connecting parts 236, 237 configured to enable the cover part 100 to be inserted between the main body part 231 and the claw parts 233, 234 and to connect the main body part 231 and the claw parts 233, 234.

[0144] The other end of the tube member 220 is connected to the main body 231. The side of the fixing member 230 to which the other end of the tube member 220 is connected is referred to as the "distal end side", and the side of the fixing member 230 where the port 211 is arranged is referred to as the "base end side".

[0145] like Fig.11 , Fig.12 As shown, the main body 231 has two claws 233 and 234. Hereinafter, the claw 233 is referred to as a "first claw 233" and the claw 234 is referred to as a "second claw 234".

[0146] The first claw portion 233 and the second claw portion 234 extend parallel to each other. A gap g2 into which the cover member 100 can be inserted is formed between the first claw portion 233 and the main body portion 231 and between the second claw portion 234 and the main body portion 231 .

[0147] like Fig.14 As shown in FIG. 1 , in the position where the first claw 233 and the second claw 234 overlap with the main body 231 in a plan view, the width w3 of the first claw 233 and the second claw 234 is smaller than the width w4 of the main body 231. The above-mentioned plan view refers to the view from the top. Fig.14 The diagram is a plan view from the bottom surface side or a plan view from the upper surface side opposite to the bottom surface side.

[0148] In this embodiment, the main body 231 has two claws 233 and 234. When the main body 231 is configured as follows, Fig.14 , Fig.17 As shown, the width w3 of the first claw portion 233 and the second claw portion 234 is defined by the distance between the outermost peripheral positions of the claw portions 233 and 234 which are farthest from the center position of the main body portion 231 .

[0149] like Fig.17As shown, the hemostatic device 10 can fix the fixing member 230 to the cover member 100 by inserting the cover member 100 between the claws 233 and 234 and the gap g2. When inserting the cover member 100 into the gap g2, the operator can easily insert the cover member 100 into the gap g2 by bringing the claws 233 and 234 close to the cover member 100 in a direction substantially parallel to the surface direction of the cover member 100. By performing the above operation, the operator can prevent the force in the direction of pressing the cover member 100 toward the body surface side of the patient's right hand H1 from being accidentally applied to the hemostatic device 10 when fixing the fixing member 230 to the cover member 100.

[0150] In addition, since the width w3 of the first claw portion 233 and the second claw portion 234 is smaller than the width w4 of the main body portion 231 , the fixing member 230 has the following effects.

[0151] When the hemostatic device is mounted on the patient's right hand H1, the cover may bend to follow the movement of the patient's right hand H1. Fig.17 As shown, the cover member 100 is bent toward the main body 231 side into a concave shape, or as shown in FIG. Fig.18 As shown, the cover part is curved into a convex shape toward the main body 231. As described above, when the cover part is curved, if the radius of curvature of the cover part (the radius of curvature when the shape of the cover part in the front view is assumed to be an arc) is too small, the cover part is likely to interfere with the claw when the cover part is inserted into the gap g2. In particular, when the width of the first claw and the second claw is greater than the width of the main body, when the cover part is curved, Fig.18 When the cover member is bent convexly toward the main body side, the cover member is more likely to interfere with the first claw and the second claw. As a result, the hemostatic device cannot smoothly insert the cover member into the gap.

[0152] In the hemostatic instrument 10, at the position where the first claw 233 and the second claw 234 overlap with the main body 231 in a plan view, the width w3 of the first claw 233 and the second claw 234 is smaller than the width w4 of the main body 231. Therefore, even when the cover member 100 is curved in a convex shape toward the main body 231 side as described above, when the cover member 100 is inserted into the gap g2, the hemostatic instrument 10 can suppress the first claw 233 and the second claw 234 from interfering with the cover member 100.

[0153] like Fig.11 , Fig.12 As shown, the main body 231 has an inclined portion 232 inclined toward the claw portions 233 and 234 .

[0154] The inclined portion 232 is configured so that at least a portion of the inclined portion 232 is located closer to the base end side than the respective front ends 233a and 234a of the claw portions 233 and 234. Fig.11In the embodiment shown, the inclined portion 232 extends from a position closer to the distal end side than the distal ends 233a and 234a of the claws 233 and 234 to a position closer to the proximal end side than the distal ends 233a and 234a of the claws 233 and 234. Fig.15 , Fig.16 As shown, when the operator inserts the cover member 100 into the gap g2, the operator moves the cover member 100 from a position closer to the front end side than the front ends 233a and 234a of the claws 233 and 234 toward the gap g2. At this time, the inclined portion 232 guides the cover member 100 toward the gap g2 while adjusting the shape of the cover member 100. Fig.11 In the embodiment, the inclined portion 232 extends from a position closer to the front end side than the front ends 233a, 234a of the claws 233, 234 to a position closer to the base end side than the front ends 233a, 234a of the claws 233, 234, so that the cover member 100 can be efficiently guided to the positions of the front ends 233a, 234a of the claws 233, 234 along the inclined portion 232. The inclined portion 232 assists the insertion of the cover member 100 into the gap g2 by guiding the movement of the cover member 100. Therefore, the operator can smoothly insert the cover member 100 into the gap g2.

[0155] like Fig.11 As shown in FIG. 2 , the main body 231 may be configured to have a cylindrical shape. Fig.12 As shown, the main body 231 may be configured to have a circular cross-sectional shape in a direction perpendicular to the extending direction of the main body 231 .

[0156] When the cover part 100 is inserted into the gap g2, the fixing part 230 may be subjected to various external forces. The main body 231 of the fixing part 230 has a circular cross-sectional shape. Therefore, when an external force is applied to the main body 231, the fixing part 230 can disperse the external force along the outer surface of the main body 231. For example, when the fixing part 230 is formed with a cross-sectional shape such as a quadrilateral, when an external force is applied to the main body 231 as described above, the external force cannot be fully dispersed along the outer surface of the main body 231. Therefore, when an external force is applied to the main body 231, there is a possibility that the hemostatic device 10 is displaced or tilted.

[0157] In addition, since the main body 231 of the fixing member 230 has a circular cross-sectional shape, Fig.17 The cover member 100 is formed into a shape that is bent into a concave shape toward the main body 231, or as shown in FIG. Fig.18Even when the cover member 100 is formed in a convex shape bent toward the main body 231, the main body 231 can be appropriately prevented from interfering with the cover member 100. For example, when the main body 231 has a cross-sectional shape such as a quadrilateral with corners, as shown in FIG. Fig.17 , Fig.18 As shown, if the cover member 100 is bent, when the cover member 100 is inserted into the gap g2, the cover member 100 interferes with the corner of the main body 231, and the cover member 100 cannot be smoothly inserted into the gap g2.

[0158] In addition, the main body 231 can also exert the effect of dispersing the external force when it has an elliptical cross-sectional shape. Therefore, from the viewpoint of exerting the effect of dispersing the external force, it is preferable that the main body 231 is formed with a circular or elliptical cross-sectional shape.

[0159] like Fig.11 , Fig.12 As shown, each claw 233, 234 has a cylindrical outer shape. Each claw 223, 234 has a flat portion 233b, 234b on the upper surface of the main body 231 side, and the flat portion 233b, 234b is configured to maintain a portion of the cover member 100 in a flat shape when the cover member 100 is inserted between the main body 231 and each claw 233, 234.

[0160] exist Fig.13 When viewed from the side as shown, each flat portion 233b, 234b extends in a straight line. Each flat portion 233b, 234b extends substantially parallel to the extension direction of the main body 231, and faces the main body 231 across a gap g2 formed between the main body 231. When the operator fixes the fixing member 230 to the cover member 100, the operator can easily insert and remove the cover member 100 into the gap g2 along the flat portions 233b, 234b of the claws 233, 234. Therefore, the operator can easily fix the fixing member 230 to the cover member 100.

[0161] like Fig.11 , Fig.13 As shown in FIG. 2 , the connecting portions 236 and 237 are bent from the main body 231 toward the front ends 233a and 234a of the claws 233 and 234. Fig.11 , Fig.13 Although the shape of the connection portion 236 is not clearly shown, the connection portion 236 has substantially the same shape as the connection portion 237 and is curved toward the front end 233 a of the first claw portion 233 similarly to the connection portion 237 .

[0162] For example, the operator can attach the hemostatic device 10 to the patient in a state where the fixing member 230 is fixed to the cover member 100. Since the connecting portions 236 and 237 of the hemostatic device 10 have the curved shape as described above, when the hemostatic device 10 is attached to the patient in a state where the fixing member 230 is connected to the cover member 100, even if the connecting portions 236 and 237 come into contact with the body surface of the patient's right hand H1, it is possible to prevent the patient from suffering pain. In addition, since the connecting portions 236 and 237 of the hemostatic device 10 have the curved shape as described above, when the patient places the right hand H1 on a table, etc., while the fixing member 230 is fixed to the cover member 100, it is possible to prevent the connecting portions 236 and 237 from biting into the skin.

[0163] like Fig.11 As shown, each front end 233a, 234a of each claw part 233, 234 can be formed in a rounded shape. Since each front end 233a, 234a of each claw part 233, 234 is formed in a rounded shape, when each claw part 233, 234 accidentally contacts with the expansion part 150, the fixing part 230 can prevent the expansion part 150 from being damaged. In addition, since each front end 233a, 234a of each claw part 233, 234 of the fixing part 230 is formed in a rounded shape, when the fixing part 230 is mounted on the cover part 100, even if each claw part 233, 234 sometimes accidentally contacts with the patient's body surface, the pain felt by the patient can be reduced.

[0164] The fixing member 230 of this embodiment has two cylindrical claws 233 and 234. Fig.28 , Fig.29 ) also explains that there is no particular limitation on the number and shape of the claws 233, 234 arranged on the fixing part 230. However, in the case where the claw is formed in a cylindrical shape, as shown in the present embodiment, it is preferably composed of two or more claws 233, 234 spaced a prescribed distance apart from each other. The reason is as follows. For example, if the fixing part 230 is configured to have one cylindrical claw, when the cover part 100 is inserted into the gap g2, the contact area between the cover part 100 and the claw becomes too small, and it is difficult to support the cover part 100 in a stable state between the claw and the main body 231. As shown in the present embodiment, by setting a prescribed distance between the two claws 233, 234, even in the case where the claw is formed in a cylindrical shape, it is possible to support the cover part 100 in a stable state between each claw 233, 234 and the main body 231.

[0165] In addition, the claw portion is preferably configured so that the cover component 100 inserted between the main body 231 and the claw portion can maintain a flat shape. In the case where the cover component 100 inserted between the main body 231 and the claw portion can maintain a flat shape, the operability when inserting and removing the claw portion relative to the cover component 100 is improved. In order to be able to exert the above-mentioned effect, the claw portion is preferably configured with a predetermined distance between the two claws, such as the two claws 233 and 234 shown in the present embodiment. The fixing component 230 is able to support the cover component 100 in a wider range of the direction in which the two claws 233 and 234 are arranged by providing a predetermined distance between the two claws 233 and 234. Thus, the fixing component 230 can maintain the cover component 100 in a flat shape between the main body 231 and each claw 233 and 234.

[0166] When the hemostatic device 10 is used to stop bleeding, the position where the fixing member 230 is fixed to the cover member 100 is not particularly limited. For example, the fixing member 230 can be fixed to the following position, that is, when the expansion member 150 is expanded, a gap is formed between the cover member 100 and the body surface of the right hand H1 so that the claws 233 and 234 of the fixing member 230 can be arranged. As such a position, a portion of the main body 110 located between the first belt portion 410 and the second belt portion 420 (see Fig. 22 ), the portion of the cover member 100 near the base end portion 122 located on the second belt body portion 420 side (refer to Fig.25 However, the position where the fixing member 230 is connected to the cover member 100 is not particularly limited as long as it is a position where the tube member 220 will not be forcibly pulled when the expansion member 150 is expanded. Fig.26 The fixing member 230 is fixed to the first belt body portion 410 as shown, or as Fig. 27 As shown, the fixing member 230 is fixed to the second belt body portion 420 .

[0167] <Example of using hemostatic instruments>

[0168] Next, refer to Figure 19 to Figure 22 An example of use of the hemostatic instrument 10 will be described.

[0169] The following describes Fig.19 The procedure for using the hemostatic instrument 10 when stopping bleeding at the first puncture site p1 formed on the patient's right hand H1 is shown.

[0170] Fig. 20 2 shows a state where various surgeries using the sheath tube 610 of the introducer sheath 600 inserted into the first puncture site p1 are completed.

[0171] When the operator installs the hemostatic device 10 on the patient's right hand H1, Fig. 20As shown, the expansion member 150 and the support member 300 are arranged to overlap with the first puncture site p1. At this time, the operator visually confirms the position of the marking portion 160 arranged on the expansion member 150 while arranging the marking portion 160 at the first puncture site p1, thereby being able to properly align the expansion member 150 and the support member 300 with the first puncture site p1.

[0172] When the operator attaches the hemostatic device 10 to the patient's right hand H1, the support member 300 can be arranged so as to overlap with the metacarpal bone B1 of the index finger and the metacarpal bone B2 of the thumb. The distance between the metacarpal bone B1 of the index finger and the metacarpal bone B2 of the thumb gradually narrows from the fingertip side toward the forearm Ar side (see Fig.19 The width of the support member 300 decreases from the upper end portion 301 disposed on the fingertip side toward the lower end portion 302 disposed on the forearm Ar side (see Figure 8 ). Therefore, the operator can arrange the support member 300 along the metacarpal bone B1 of the index finger and the metacarpal bone B2 of the thumb by arranging the support member 300 from the back of the right hand H1 of the patient so as to overlap with the metacarpal bone B1 of the index finger and the metacarpal bone B2 of the thumb. The operator can prevent a gap from being formed between the expansion member 150 arranged on the inner surface 300a side of the support member 300 and the right hand H1 by arranging the support member 300 along the metacarpal bone B1 of the index finger and the metacarpal bone B2 of the thumb.

[0173] like Fig.21 As shown in FIG. 1 , the operator winds the second belt body 420 and the third belt body 430 along the outer circumference of the patient's right hand H1. The operator fixes the third fixing portion 530 (see FIG. 1 ) disposed on the inner surface of the second belt body 420. Figure 1 ) and the second fixing portion 520 (refer to Figure 2 ) are in contact with the second belt body 420 and the third belt body 430 via the fixing portions 520 and 530. The operator connects the belt bodies 420 and 430 to each other while overlapping the support member 300 with the metacarpal bone B1 of the index finger and the metacarpal bone B2 of the thumb, thereby being able to firmly wind the belt bodies 420 and 430 along the outer periphery of the right hand H1.

[0174] The outer surface 300b of the supporting member 300 is curved toward the second belt body 420 side (the side surface 303 side) and the third belt body 430 side (the side surface 304 side) (see Figure 5 , Figure 7 , Fig. 9 ). Therefore, the surgeon Fig.21 As shown in FIG. 1 , the second belt body 420 and the third belt body 430 are wound around the right hand H1 of the patient, so that Fig.24As shown, the support member 300 is pressed against the right hand H1 from the outer surface 300b side along the outer periphery of the right hand H1. Therefore, the hemostatic instrument 10 can enhance the fixing force of the support member 300 and the expansion member 150 against the patient's right hand H1.

[0175] like Fig. 22 As shown, the operator passes the first belt body 410 through the interdigital portion fb between the thumb and index finger of the patient's right hand H1, and places a portion of the first belt body 410 on the palm side of the patient's right hand H1. At this time, the operator places the fourth fixing portion 540 (see FIG. 5 ) disposed on the inner surface of the first belt body 410. Figure 2 ) and the first fixing portion 510 (refer to Figure 1 ) are in contact, so that the first belt body portion 410 and the second belt body portion 420 can be connected via the fixing portions 510 and 540.

[0176] There are inclined portions in various parts of the patient's right hand H1 (eg, around the snuff box Sb) (see Fig.19 ). In addition, the shape of the inclined portion of the right hand H1 is affected by individual differences among patients. For example, when the inner surface of the support member is formed in a flat shape, it is difficult to arrange the support member along the inclined portion of the right hand H1. The inner surface 300a of the support member 300 of the hemostatic device 10 is curved into a convex shape as it moves away from the expansion member 150 (see Figure 7 , Fig.24 ). Therefore, by arranging the inner surface 300a of the support member 300 to overlap with the inclined portion of the patient's right hand H1, the inner surface 300a of the support member 300 can be arranged along the patient's right hand H1. As a result, the hemostatic device 10 can overlap the support member 300 at the first puncture site p1 without depending on the dominant hand of the patient or the placement method of the operator. Therefore, the hemostatic device 10 can appropriately arrange the support member 300 at a desired position near the first puncture site p1.

[0177] After the hemostatic device 10 is mounted on the patient's right hand H1 through the above steps, the operator connects the syringe to the port 211. The operator operates the syringe to inject air into the expansion member 150 to expand the expansion member 150. Fig.23 , Fig.24 As shown, when the expansion member 150 is expanded, the expansion member 150 applies a compressive force to the first puncture site p1.

[0178] When the expansion member 150 expands while the hemostatic instrument 10 is attached to the patient's right hand H1, the support member 300 made of a harder material than the expansion member 150 presses the expansion member 150 against the patient's right hand H1. Thus, the hemostatic instrument 10 can prevent the expansion member 150 from floating from the patient's right hand H1.

[0179] When the operator uses the hemostatic device to stop bleeding, in order to increase the fixing force of the support member relative to the patient's right hand H1, for example, the first belt body portion arranged at the interdigital part fb can be strongly fastened. By strongly fastening the first belt body portion, the operator can firmly fix the support member to the patient's right hand H1 even if the support member is arranged on the patient's right hand H1 in an unstable state. However, if the first belt body portion is strongly fastened, the patient may feel pain. Therefore, in the case where the first belt body portion cannot be strongly fastened due to the patient's pain, the hemostatic device has a configuration in which the inner surface of the support member is tilted relative to the body surface of the patient's right hand H1. Specifically, it floats to a position where the upper end of the support member where the first belt body portion is arranged is excessively separated from the body surface of the patient's right hand H1 compared to the lower end located on the opposite side of the upper end. As a result, the support member of the hemostatic device is tilted so that the distance between the inner surface of the support member and the body surface of the patient's right hand H1 gradually narrows from the upper end of the support member toward the lower end.

[0180] The hemostatic device 10 is configured such that the thickness t1 of the side portions 303 and 304 of the supporting member 300 becomes thinner from the upper end portion 301 toward the lower end portion 302. Furthermore, the first belt portion 410, which is arranged in the interdigital portion fb located between the patient's fingers, is configured to extend from the upper end portion 301 side of the supporting member 300 to press the upper end portion 301 side of the supporting member 300 against the patient's right hand H1. In the hemostatic device 10 configured in this way, in a state where the supporting member 300 and the expansion member 150 are fixed to the patient's right hand H1, when the expansion member 150 begins to expand, the expansion member 150 applies a force to the vicinity of the upper end portion 301 of the supporting member 300. The supporting member 300 is lifted up by the force applied by the expansion member 150. Thus, in a state where the expansion member 150 is expanded, as shown in FIG. Fig.23 As shown, the inner surface 300a of the support member 300 is arranged substantially parallel to the body surface of the patient's right hand H1. Therefore, when the expansion member 150 is expanded, the hemostatic instrument 10 can apply a compressive force in a direction perpendicular to the first puncture site p1.

[0181] The inner surface 300a of the supporting member 300 is curved toward the second belt body 420 side and the third belt body 430 side (see Figure 7 ).like Fig.24As shown in FIG. 1 , the hemostatic device 10 is arranged such that, in a state where the expandable member 150 is expanded, the inner surface 300a of the support member 300 is along the body surface of the patient's right hand H1. When the expandable member 150 is expanded, the hemostatic device 10 presses the expandable member 150 by the inner surface 300a of the support member 300 in a manner along the body surface of the patient's right hand H1. Thus, when the expandable member 150 is expanded, the expandable member 150 applies a compressive force in a direction toward the first puncture site p1 from the center side in the width direction of the inner surface 300a of the support member 300 and the side surfaces 303 and 304 located at both ends in the width direction of the inner surface 300a of the support member 300. Therefore, compared with a case where the inner surface 300a of the support member 300 is formed in a flat surface shape, the hemostatic device 10 can effectively increase the compressive force applied by the expandable member 150 to the first puncture site p1.

[0182] After the operator expands the expansion member 150, Fig. 22 As shown, the sheath tube 610 of the guide sheath 600 is pulled out from the first puncture site p1. The operator confirms that there is no bleeding from the first puncture site p1 while using the hemostatic device 10 to stop bleeding. The operator can adjust the amount of air injected into the expansion member 150 when there is bleeding at the first puncture site p1.

[0183] Through the above steps, the operator can use the hemostatic instrument 10 to stop bleeding at the first puncture site p1 formed on the patient's right hand H1.

[0184] The operator can expand the expansion member 150 to perform Fig. 22 As shown, the fixing member 230 is fixed to the cover member 100. By fixing the fixing member 230 to the cover member 100, the operator can prevent the tube member 220 from moving along with the movement of the patient's right hand H1 when the hemostatic device 10 is installed. It should be noted that the operator may fix the fixing member 230 to the cover member 100 before expanding the expansion member 150, and expand the expansion member 150 after installing the hemostatic device 10 on the patient's right hand H1.

[0185] As described above, the hemostatic instrument 10 of the present embodiment includes: the cover member 100 configured to cover the first puncture site p1; the expansion member 150 configured to be connected to the cover member 100 and to compress the first puncture site p1; the injection member 200 configured to be connected to the expansion member 150 and capable of injecting a fluid into the expansion member 150; and the fixing member 230 configured to fix the injection member 200 to the cover member 100. The injection member 200 includes the connector portion 210 and the tube member 220 connected to the expansion member 150. The fixing member 230 includes: the main body portion 231 connecting the connector portion 210 and the tube member 220; the claw portions 233 and 234 extending parallel to the main body portion 231 toward the expansion member 150 side; and the connecting portions 236 and 237 configured to connect the main body portion 231 and the claw portions 233 and 234 so that the cover member 100 can be inserted between the main body portion 231 and the claw portions 233 and 234. In a position where the claws 233 and 234 overlap with the main body 231 in a plan view, a width w3 of the claws 233 and 234 is smaller than a width w4 of the main body 231 .

[0186] The hemostatic instrument 10 configured as described above can fix the injection member 200 to the cover member 100 by inserting the cover member 100 between the main body 231 and the claws 233 and 234 in a state where the main body 231 of the fixing member 230 connects the connector part 210 and the tube member 220. When the operator inserts the cover member 100 between the main body 231 and the claws 233 and 234, the fixing member 230 is brought close to the cover member 100 in a direction substantially parallel to the surface direction of the cover member 100, so that the cover member 100 can be inserted between the main body 231 and the claws 233 and 234. Therefore, when the operator fixes the injection member 200 to the cover member 100, it is possible to prevent an unnecessary force from being applied in a direction in which the hemostatic instrument 10 is pressed against the body surface of the patient's right hand H1. Therefore, when the injection part 200 is fixed to the cover part 100, the hemostatic device 10 can prevent the hemostatic device 10 mounted on the right hand H1 of the patient from being displaced or the expansion part 150 from being displaced. In addition, for example, when the hemostatic device 10 is mounted on the patient, the cover part 100 may bend to follow the movement of the body. In the case where the width w3 of the claws 233 and 234 is formed to be larger than the width w4 of the main body 231 at the position where the claws 233 and 234 overlap with the main body 231, if the cover part 100 is bent, when the cover part 100 is inserted between the main body 231 and the claws 233 and 234, the claws 233 and 234 are likely to interfere with the cover part 100. In the hemostatic device 10, in the position where the claws 233 and 234 overlap with the main body 231 in a plan view, the width w3 of the claws 233 and 234 is smaller than the width w4 of the main body 231. Therefore, even when the cover member 100 bends to follow the movement of the patient's right hand H1, the hemostatic instrument 10 can smoothly insert the cover member 100 between the main body 231 and the claws 233 and 234.

[0187] In addition, the hemostatic instrument 10 of the present embodiment includes: a cover member 100 configured to cover the first puncture site p1; an expansion member 150 configured to be connected to the cover member 100 and to compress the first puncture site p1; an injection member 200 configured to be connected to the expansion member 150 and capable of injecting a fluid into the expansion member 150; and a fixing member 230 configured to fix the injection member 200 to the cover member 100. The injection member 200 includes a connector portion 210 and a tube member 220 connected to the expansion member 150. The fixing member 230 includes a main body portion 231 connecting the connector portion 210 and the tube member 220; claw portions 233 and 234 extending parallel to the main body portion 231 toward the expansion member 150 side; and connecting portions 236 and 237 configured to allow the cover member 100 to be inserted between the main body portion 231 and the claw portions 233 and 234 and to connect the main body portion 231 and the claw portions 233 and 234. The main body 231 has an inclined portion 232 inclined toward the claws 233 and 234 , and at least a portion of the inclined portion 232 is located closer to the base end than the front ends 233 a and 234 a of the claws 233 and 234 in the main body 231 .

[0188] In the state where the main body 231 of the fixing member 230 connects the connector part 210 and the tube part 220, the hemostatic instrument 10 configured as described above can fix the injection member 200 to the cover member 100 by inserting the cover member 100 between the main body 231 and the claws 233 and 234. When the operator inserts the cover member 100 between the main body 231 and the claws 233 and 234, the fixing member 230 is brought close to the cover member 100 in a direction substantially parallel to the surface direction of the cover member 100, so that the cover member 100 can be inserted between the main body 231 and the claws 233 and 234. Therefore, when the operator fixes the injection member 200 to the cover member 100, it is possible to prevent the hemostatic instrument 10 from being applied in the direction of pressing the body surface of the right hand H1 of the patient. Therefore, when the injection member 200 is fixed to the cover member 100, the hemostatic device 10 can prevent the hemostatic device 10 mounted on the patient's right hand H1 from being displaced or the expansion member 150 from being displaced. In addition, the hemostatic device 10 is configured such that the main body 231 has an inclined portion 232 inclined toward the claws 233 and 234. In addition, at least a part of the inclined portion 232 of the main body 231 is configured to be located at a position closer to the base end side than the front ends 233a and 234a of the claws 233 and 234 in the main body 231. Therefore, the hemostatic device 10 is configured such that when the operator inserts the cover member 100 between the main body 231 and the claws 233 and 234, the inclined portion 232 guides the cover member 100 to a position closer to the connecting portions 236 and 237 than the front ends 233a and 234a of the claws 233 and 234. Therefore, when inserting the cover part 100 between the main body 231 and the claws 233 , 234 , the operator can guide the cover part 100 along the inclined portion 232 , thereby adjusting the shape of the cover part 100 while smoothly inserting the cover part 100 between the main body 231 and the claws 233 , 234 .

[0189] The main body 231 has an inclined portion 232 inclined toward the claws 233 and 234. The inclined portion 232 extends from a position closer to the distal end than the distal ends 233a and 234a of the claws 233 and 234 to a position closer to the proximal end than the distal ends 233a and 234a of the claws 233 and 234.

[0190] According to the hemostatic instrument 10 configured as described above, when the cover member 100 is inserted into the gap g2, the inclined portion 232 efficiently guides the cover member 100 to the positions of the front ends 233a and 234a of the claws 233 and 234. When the cover member 100 is inserted into the gap g2, the inclined portion 232 assists the insertion of the cover member 100 into the gap g2. Therefore, the operator can smoothly insert the cover member 100 into the gap g2.

[0191] The main body portion 231 may be configured to have a circular or elliptical cross-sectional shape.

[0192] According to the hemostatic instrument 10 configured as described above, the fixing member 230 can disperse the external force along the outer surface of the main body 231 when the external force is applied to the main body 231. Therefore, it is possible to prevent the hemostatic instrument 10 from being displaced or tilted when the external force is applied to the main body 231. In addition, even when the cover member 100 is formed in a shape that is curved concavely toward the main body 231 side or the cover member 100 is formed in a shape that is curved convexly toward the main body 231 side, it is possible to appropriately prevent the main body 231 from interfering with the cover member 100 when the cover member 100 is inserted into the gap g2.

[0193] The claws 233 and 234 have flat portions 233b and 234b configured to maintain a portion of the cover member 100 in a flat shape when the cover member 100 is inserted between the main body 231 and the claws 233 and 234. The flat portions 233b and 234b face the main body 231 across a gap g2 formed between the main body 231 and the claws 233 and 234.

[0194] According to the hemostatic instrument 10 configured as described above, when fixing the fixing member 230 to the cover member 100 , the operator can easily insert and remove the cover member 100 into the gap g2 along the flat portions 233b and 234b of the claws 233 and 234 .

[0195] Each of the connection portions 236 and 237 has a shape that is bent from the main body portion 231 toward the front ends 233 a and 234 a of the claw portions 233 and 234 .

[0196] According to the hemostatic instrument 10 configured as described above, even if the connecting portions 236 and 237 may come into contact with the body surface of the right hand H1 of the patient when the hemostatic instrument 10 is attached to the patient in the state where the fixing member 230 is connected to the fixing cover member 100, it is possible to prevent the patient from suffering pain, etc. In addition, since the connecting portions 236 and 237 of the hemostatic instrument 10 have the curved shape as described above, it is possible to prevent the connecting portions 236 and 237 from biting into the skin when the patient places the right hand H1 on a table, etc., while the fixing member 230 is fixed to the cover member 100.

[0197] The cover member 100 includes: a main body 110 where the expansion member 150 is located; a first belt portion 410 configured to be arranged between fingers of a patient and extending from the main body 110 in a first direction; a second belt portion 420 extending from the main body 110 in a second direction different from the first direction; and a third belt portion 430 that is opposite to the second belt portion 420 across the expansion member 150 and extends from the main body 110 in a direction different from the first belt portion 410 and the second belt portion 420. The claws 233 and 234 are configured to be able to insert any one of the main body 110, the first belt portion 410, the second belt portion 420, and the third belt portion 430 of the cover member 100 between the connecting portions 236 and 237.

[0198] According to the hemostatic instrument 10 configured as described above, the fixing member 230 can be fixed to any position of the cover member 100 provided in the hemostatic instrument 10, and the hemostatic instrument 10 is configured to be attachable to the right hand H1. Therefore, the convenience of the hemostatic instrument 10 is improved.

[0199] Next, a modification of the first embodiment is described. In the description of the modification, descriptions of components and the use procedures of the hemostatic device that have been described in the first embodiment are appropriately omitted. In addition, the contents not particularly described in the modification may be the same as those in the first embodiment.

[0200] <Modification 1>

[0201] Fig.28 It is a side view of the fixing member 230A according to the first modification. Fig.29 It is along Fig.28 A cross-sectional view taken along arrows 29A-29A is shown.

[0202] like Fig.28 , Fig.29 As shown, the fixing member 230A includes a claw portion 233A.

[0203] The claw portion 233A includes a flat portion 233b configured to maintain a portion of the cover member 100 in a flat shape when the cover member 100 is inserted between the main body portion 231 and the claw portion 233A. Fig.29 As shown in FIG. 1 , the flat portion 233b of the claw portion 233A of this modification extends parallel to the extension direction of the main body portion 231. Fig.28 The flat portion 233 b extends in a straight line in the side view shown. The flat portion 233 b faces the main body 231 across a gap g2 formed between the main body 231 and the claw portion 233A.

[0204] The fixing member 230A includes one claw portion 233A. The claw portion 233A is connected to the main body portion 231 via a connecting portion 236A.

[0205] like Fig.29 As shown in FIG. 1 , the claw portion 233A has a rectangular shape when viewed from the front. The flat portion 233b forms the upper surface of the claw portion 233A on the side of the main body portion 231. Fig.29 As shown in the cross-sectional view, the flat portion 233b of the modification 1 forms a plane extending in a straight line in the width direction of the claw portion 233A. Therefore, when the cover part 100 is inserted between the main body 231 and the claw portion 233A, the claw portion 233A can maintain a portion of the cover part 100 in a flat shape over a large range. The claw portion 233A extends in a generally straight line toward the front end 233a. The connecting portion 236A can be configured to extend in a generally straight line between the main body 231 and the claw portion 233A, for example.

[0206] like Fig.29 As shown, in the position where the claw portion 233A overlaps the main body 231 in front view, the width w3' of the claw portion 233A is smaller than the width w4' of the main body 231. The above-mentioned width relationship in front view is also the same when the fixing member 230A is viewed from above.

[0207] The claw portion 233A of the fixing member 230A of the modification 1 has a straight flat portion 233b opposite to the main body 231 across the gap g2 formed between the main body 231 and the claw portion 233A. The claw portion 233A of the fixing member 230A has a simple structure extending in a straight line. When the operator connects the fixing member 230A to the cover member 100, the cover member 100 can be easily inserted and removed relative to the gap g2 along the flat portion 233b. Therefore, the operator can easily fix the fixing member 230A to the cover member 100.

[0208] <Modification 2>

[0209] Fig.30 It is a side view of a fixing member 230B according to Modification 2.

[0210] The fixing member 230B of Modification 2 has a first protrusion 238a formed on the main body 231 and a second protrusion 238b formed on the claw 233A. The first protrusion 238a protrudes from the main body 231 toward the gap g2. The second protrusion 238b protrudes from the claw 233A toward the gap g2.

[0211] The first convex portion 238a can be arranged, for example, at a position closer to the base end side of the fixing member 230B than the second convex portion 238b. In addition, the second convex portion 238b can be arranged at the front end 233a of the claw portion 233A.

[0212] In a state where the cover member 100 is inserted into the gap g2, the fixing member 230B of the second modification makes the projections 238a and 238b contact the cover member 100. Therefore, the cover member 100 is unlikely to fall off from the gap g2.

[0213] In addition, the number, position, cross-sectional shape, etc. of the convex portions arranged on the fixing member 230B are not particularly limited. In addition, the convex portions may be arranged on the fixing member 230 having the claw portions 233 and 234 of the structure shown in the first embodiment. In addition, the convex portions may be arranged only on the main body 231 or only on the claw portions.

[0214] <Variation 3>

[0215] Fig.31 It is a side view of a fixing member 230C according to Modification 3.

[0216] The main body 231 of the fixing member 230C of the modification 3 is provided with a plurality of protrusions 239. The plurality of protrusions 239 function as anti-slip members when the operator holds the main body 231 with fingers. Therefore, the operator can more smoothly perform the operation of fixing the fixing member 230C to the cover member 100. In addition, the main body 231 of the fixing member 230C can also be made of a material that is difficult to slide. The fixing member 230C can also exert the same effect as described above when it is configured in this way.

[0217] <Fourth Modification>

[0218] like Fig.32 , Fig.33 As shown, the fixing member 230 can also be applied to the hemostatic instrument 10A configured to be attachable to the patient's arm, for example.

[0219] The hemostatic device 10A includes: a cover member 810 in a belt-like shape that can be fixed in a state of being wound around the patient's arm; and an expansion member 820 disposed on the cover member 810. The expansion member 820 is connected to the tube member 220. The tube member 220 is connected to the main body 231 of the fixing member 230. When the hemostatic device 10A is used to stop bleeding, for example, Fig.32 , Fig.33 As shown, by inserting the cover member 810 into the gap g2 (refer to Fig.17 , Fig.18 ), thereby enabling the fixing component 230 to be fixed at a specified position of the cover component 810.

[0220] It should be noted that, similar to the hemostatic instrument 10 of the aforementioned embodiment, the hemostatic instruments of the above-mentioned modified examples 1 to 4 have an inclined portion 232 (see Fig.28 , Fig.30 , Fig.31 , Fig.32 The inclined portion 232 of each modified example is inclined toward the claw portion. In addition, at least a portion of the inclined portion 232 is configured to be located closer to the base end side than the front end of the claw portion in the main body.

[0221] <Second Embodiment>

[0222] Next, the fixing member of the second embodiment of the present invention is described. In the description of the second embodiment, the description of the members and the use steps of the hemostatic device that have been described in the first embodiment are appropriately omitted. In addition, the contents not particularly described in the second embodiment may be the same as those in the first embodiment.

[0223] Fig.34 , Fig.35 , Fig.36 A fixing member 700 according to a second embodiment is shown.

[0224] The fixing member 700 of the second embodiment is configured to be attachable to and detachable from the pipe member 220 .

[0225] like Fig.36 As shown, the hemostatic device of the second embodiment includes: a cover part 100 configured to cover the first puncture site p1; an expansion part 150 configured to be connected to the cover part 100 and to compress the first puncture site p1; an injection part 900 connected to the expansion part 150 and configured in a manner capable of injecting a fluid into the expansion part 150; and a fixing part 700 configured to fix the injection part 900 to the cover part 100.

[0226] The injection member 900 includes a connector portion 901 and a tube member 903 that connects the connector portion 901 and the expansion member 150 .

[0227] A buffer member 902 having an expandable space is disposed between the tube member 903 and the connector portion 901. The buffer member 902 is formed of a flexible bag-shaped member having a space formed therein. In addition, an arrow-shaped mark indicating the direction in which the syringe is inserted into the connector portion 901 may be provided on the buffer member 902. When air is injected into the inner cavity 150a of the expansion member 150, the expansion member 150 expands. When the expansion member 150 expands, the buffer member 902 connected to the inner cavity 150a of the expansion member 150 via the tube member 903 expands. The operator can visually confirm the expansion of the buffer member 902 and understand that the expansion member 150 has expanded without air leakage.

[0228] like Fig.34 , Fig.35As shown, the fixing component 700 includes: a main body 710 having a groove 711 capable of fixing the tube component 903; a first claw 720 extending from the main body 710; and a second claw 730 extending parallel to the first claw 720 and forming a gap g3 between the first claw 720 and the second claw 730 into which the cover component 100 can be inserted.

[0229] Through the tube member 903 along Fig.34 The fixing member 700 is pressed into the groove portion 711 in the direction indicated by the arrow D, so that the pipe member 903 and the main body 710 can be connected.

[0230] The fixing member 700 can be fixed to the cover member 100 by inserting the cover member 100 into the gap g3 between the first claw portion 720 and the second claw portion 730 .

[0231] The first claw portion 720 includes a root portion 721 connected to the main body portion 710 and a tapered portion 724 extending toward the distal end of the root portion 721. The tapered portion 724 is configured to gradually decrease in thickness toward the distal end of the first claw portion 720.

[0232] The second claw 730 includes a root 731 connected to the main body 710 and a tapered portion 734 extending toward the front end of the root 731. The tapered portion 734 is configured to gradually become thinner toward the front end of the second claw 730. The front end of the tapered portion 734 of the second claw 730 is disposed at a position farther from the main body 710 than the front end of the tapered portion 724 of the first claw 720. That is, the length of the second claw 730 in the extending direction is longer than the length of the first claw 720 in the extending direction.

[0233] When the cover member 100 is inserted into the gap g3, the fixing member 700 is guided to be inserted into the gap g3 along the tapered portion 734 of the second claw portion 730. Therefore, the operator can smoothly insert the cover member 100 into the gap g3.

[0234] The fixing member 700 is connected to the hemostatic device via the tube member 903 by inserting the tube member 903 into the groove 711. Therefore, the fixing member 230 is separated from the hemostatic device when the tube member 903 is not inserted into the groove 711. The fixing member 700 can be packaged together with the hemostatic device in a state separated from the hemostatic device before the hemostatic device is used (in a state of transportation or storage). The operator can connect the tube member 903 to the fixing member 700 when starting to stop bleeding using the hemostatic device. Fig.36 As shown, the operator can fix the fixing member 700 connected to the tube member 903 at any position of the cover member 100 .

[0235] The operator can prevent the tube member 903 from moving along with the movement of the patient's right hand H1 when the hemostatic device is attached to the patient's right hand H1 by fixing the fixing member 700 to the cover member 100. In addition, the fixing member 700 can be fixed to the cover member 100 by bringing the fixing member 700 close to the cover member 100 in a direction substantially parallel to the surface direction of the cover member 100 when the fixing member 700 and the cover member 100 are connected. Therefore, when the fixing member 700 is fixed to the cover member 100, it is possible to prevent the force in the direction of pressing the expansion member 150 against the body surface of the patient's right hand H1 from being applied to the hemostatic device 10.

[0236] As mentioned above, the hemostatic instrument according to the present invention has been described by using a plurality of embodiments and modified examples. However, the present invention is not limited to the contents described in the specification, and can be appropriately modified based on the description of the claims.

[0237] The shapes and dimensions of the various parts of the hemostatic device are not particularly limited as long as the expansion member disposed at the puncture site can compress and stop bleeding, and can be appropriately changed.

[0238] The specific shapes (planar shape, cross-sectional shape) of the expansion member and the support member are not limited to the shapes shown in the embodiments.

[0239] For example, in order to reduce the load on the patient's body to which the hemostatic device is attached or to provide a good skin touch during attachment, a part or the entirety of the fixing member may be made of a soft material. In addition, the fixing member may also be configured to have a clip structure, which makes the distance between the claw and the main body variable by utilizing the elastic force of an elastic member or the like. In the case where the fixing member is configured to have the above-mentioned clip structure, the fixing member and the cover member can be easily fixed and released by opening and closing the clip.

[0240] This application is based on Japanese Patent Application No. 2022-44655 filed on March 18, 2022, and the disclosed contents are incorporated herein by reference in their entirety.

[0241] Description of Reference Numerals

[0242] 10. Hemostatic Devices

[0243] 10A hemostatic device

[0244] 100 Cover Parts

[0245] 110 Main body

[0246] 120 sheets

[0247] 150 expansion parts

[0248] 150a Inner cavity of expansion member

[0249] 200 injection parts

[0250] 210 Connector

[0251] 211 Port Department

[0252] 213 Valve Department

[0253] 220 pipe parts

[0254] 230 fixed parts

[0255] 231 Main body of the fixing component

[0256] 232 inclined part

[0257] 233 1st claw part (claw part)

[0258] 233a Front end of the first claw

[0259] 234 2nd claw part (claw part)

[0260] 234a Front end of the second claw

[0261] 236 Connection

[0262] 237 Connection

[0263] 230A fixed parts

[0264] 233A Claw

[0265] 233b Flat part

[0266] 230B fixed parts

[0267] 238a 1st convex part (convex part)

[0268] 238b 2nd convex part (convex part)

[0269] 230C fixed parts

[0270] 239 protrusion

[0271] 300 Support components

[0272] 410 1st belt body

[0273] 420 2nd belt body

[0274] 430 3rd belt body

[0275] 600 Introducer Sheath

[0276] 700 fixed parts

[0277] 710 Main body of the fixing component

[0278] 711 slot

[0279] 720 1st claw

[0280] 730 Second Claw

[0281] 900 injection parts

[0282] 901 Connector

[0283] 902 buffer parts

[0284] 903 pipe parts

[0285] G2 The gap between the main body and the claw

[0286] g3 Gap between the main body and the claw

[0287] w3 Width of claw

[0288] w4 Width of the main body of the fixing member

[0289] H Hand

[0290] H1 Right Hand

[0291] Ar forearm

[0292] fb finger

[0293] Sb snuff box

[0294] B1 Metacarpal bone of index finger

[0295] B2 Metacarpal bone of thumb

[0296] T1 extensor pollicis longus tendon

[0297] T2 extensor pollicis brevis tendon

[0298] V1 vessel (distal radial artery)

[0299] V2 is the artery located in the snuffbox

[0300] p11st puncture site (puncture site)

[0301] p2 Second puncture site (puncture site)

Claims

1. A hemostatic device, characterized in that: include: a cover member configured to cover a puncture site formed on a patient; an expansion member connected to the cover member and configured to compress the puncture site; an injection component connected to the expansion component and configured to inject a fluid into the expansion component; as well as a fixing member configured to fix the injection member to the cover member, The injection member includes a connector portion and a tube member connected to the expansion member. The fixing member includes: a main body portion connecting the connector portion and the tube portion; and a claw portion extending toward the expansion member side in parallel with the main body portion. and a connecting portion configured to connect the main body and the claw by inserting the cover member between the main body and the claw, In a position where the claw portion overlaps the main body portion in a plan view, a width of the claw portion is smaller than a width of the main body portion.

2. The hemostatic device according to claim 1, characterized in that: The main body has an inclined portion inclined toward the claw portion. The inclined portion extends from a position closer to the distal end than the distal end of the claw portion to a position closer to the proximal end than the distal end of the claw portion.

3. The hemostatic device according to claim 1 or 2, characterized in that: The main body has a circular or elliptical cross-sectional shape.

4. The hemostatic device according to any one of claims 1 to 3, characterized in that: The claw portion has a flat portion configured to maintain a portion of the cover member in a flat shape when the cover member is inserted between the main body portion and the claw portion. The flat portion faces the main body portion via a gap formed between the main body portion and the claw portion.

5. The hemostatic device according to any one of claims 1 to 4, characterized in that: The connection portion is bent from the main body portion toward a front end side of the claw portion.

6. The hemostatic device according to any one of claims 1 to 5, characterized in that: The main body and / or the claw has a convex portion that protrudes toward a gap formed between the main body and the claw.

7. The hemostatic device according to any one of claims 1 to 6, characterized in that: The cover member includes: a main body portion where the expansion member is located; a first belt portion, which is configured to be arranged between the patient's fingers and extends from the main body portion of the cover member in a first direction; a second belt portion, which extends from the main body portion of the cover member in a second direction different from the first direction; and a third belt portion, which is opposite to the second belt portion across the expansion member and extends from the main body portion of the cover member in a direction different from the first belt portion and the second belt portion. The claw portion is configured so that any one of the main body portion of the cover member, the first belt portion, the second belt portion, and the third belt portion is inserted between the claw portion and the connecting portion.

8. A hemostatic device, characterized in that: include: a cover member configured to cover a puncture site formed on a patient; an expansion member connected to the cover member and configured to compress the puncture site; an injection component connected to the expansion component and configured to inject a fluid into the expansion component; as well as a fixing member configured to fix the injection member to the cover member, The injection member includes a connector portion and a tube member connecting the connector portion and the expansion member. The fixing member comprises: a main body formed with a groove capable of fixing the tube member; a first claw extending from the main body; and a second claw extending parallel to the first claw and forming a gap between the first claw and the second claw into which the cover member can be inserted.

9. A hemostatic device, characterized in that: include: a cover member configured to cover a puncture site formed on a patient; an expansion member connected to the cover member and configured to compress the puncture site; an injection component connected to the expansion component and configured to inject a fluid into the expansion component; as well as a fixing member configured to fix the injection member to the cover member, The injection member includes a connector portion and a tube member connected to the expansion member. The fixing member includes: a main body portion connecting the connector portion and the tube portion; and a claw portion extending toward the expansion member side in parallel with the main body portion. and a connecting portion configured to connect the main body and the claw by inserting the cover member between the main body and the claw, The main body has an inclined portion inclined toward the claw portion. At least a part of the inclined portion is configured to be located closer to the base end side than the front end of the claw portion in the main body portion.

10. The hemostatic device according to claim 9, characterized in that: The claw portion has a flat portion configured to maintain a portion of the cover member in a flat shape when the cover member is inserted between the main body portion and the claw portion. The flat portion faces the main body portion via a gap formed between the main body portion and the claw portion.

11. The hemostatic device according to claim 9 or 10, characterized in that: In a position where the claw portion overlaps the main body portion in a plan view, a width of the claw portion is smaller than a width of the main body portion.